2017-10-10 22:47:52 UTC

Apply Biomarkers to Better Target Therapies to IBD Patients

Oct. 12, 2017

Dr. Lee A. Denson will present his findings on biomarkers in Las Vegas at the Crohn’s & Colitis Congress.

Science and treatment advances are moving fast in inflammatory bowel diseases (IBD), and it is imperative to stay up-to-date and apply the latest research and clinical algorithms to improve care for patients. Hear from foremost IBD researchers and practitioners at the Crohn’s & Colitis Congress™ on Jan. 18-20, 2018 in Las Vegas, as you learn alongside multi-disciplinary IBD professionals to form an all-inclusive care perspective.

In Dr. Lee A. Denson’s presentation Biomarkers for Precision Medicine, you’ll learn how to apply current and upcoming biomarkers in clinical practice to better target therapies to individual patients. Recent studies have validated biomarkers that can be used now to improve patient outcomes and guide therapeutic choices.

The Crohn’s & Colitis Congress is a partnership of the Crohn’s & Colitis Foundation and AGA. Learn more, submit an abstract and register today at www.crohnscolitiscongress.org.

More on Crohn's Disease

Blog: What Happens When Patients With Crohn’s Disease in Remission Stop Taking Infliximab?

Feb. 21, 2018

Researchers report that fewer than one fifth of patients required surgery. Read more on the AGA Journals Blog.

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Building an IBD Specialty Clinic from the Ground Up

Feb. 7, 2018

Gastro One in Tennessee developed an IBD clinic within their practice, which decreased emergency room visits by 70 percent.